Opioid Advocacy Update From the beginning of the opioid epidemic, the California Medical Association (CMA) has been one of the most engaged and determined stakeholders working to strike a balance between patient access to necessary medicine and preventing and addressing abuse. September 28, 2018 California Legislation, Health Care Reform, Legislation, Resources cma, controlled substances, CURES, opiod, opiod advocacy, opiod crisis, opiod enforcement, opiod epidemic, prescribing opiods, prescription drugs 0 0 Comment Read More »
Are You Ready to Check CURES? Effective October 2, 2018, physicians must consult California’s prescription drug monitoring database (the Controlled Substance Utilization Review and Evaluation System, or CURES) – prior to prescribing Schedule II, III or IV controlled substances. All individuals practicing in California who possess both a state regulatory board license authorized to prescribe, dispense, furnish or order controlled substances and a Drug Enforcement Administration Controlled Substance Registration Certificate must be registered to use CURES. June 19, 2018 California Legislation, Legislation, RCMA/CMA controlled substances, CURES, opiods, prescription drugs 0 0 Comment Read More »